Search research articles
Contact Us
Filters
Showing results (1-10 of 548) with videos related to
Page
of 55
Sort By:
Clinical Chemistry
|
February 17, 2019
Technology Meets Opportunity: High-Sensitivity Troponin Testing for Screening Apparently Healthy Adults
James A de Lemos
JAMA
|
June 6, 2013
Increasingly sensitive assays for cardiac troponins: a review
James A de Lemos
Archives of Internal Medicine
|
December 13, 2006
The latest and greatest new biomarkers: which ones should we measure for risk prediction in our practice?
James A de Lemos
JAMA
|
October 10, 2013
Assays for cardiac troponins--reply
James A de Lemos
Circulation. Cardiovascular Genetics
|
December 25, 2009
The report card on growth differentiation factor 15: consistent marks but not yet ready for promotion
Anand Rohatgi, James A de Lemos
Current Cardiology Reports
|
June 13, 2003
B-type natriuretic peptide in ischemic heart disease
Rajat Deo, James A de Lemos
Journal of the American College of Cardiology
|
November 21, 2007
The skinny on fatty acid-binding protein
James A de Lemos, Michelle O'Donoghue
Circulation
|
May 26, 2010
Separating the contenders from the pretenders: competitive high-throughput biomarker screening in large population-based studies
James A de Lemos, Anand Rohatgi
The New England Journal of Medicine
|
March 2, 2022
High-Sensitivity Troponin after Cardiac Surgery - Is the VISION Any Clearer?
James A de Lemos, Michael Jessen
Heart Failure Reviews
|
October 24, 2003
Natriuretic peptide hormone measurement in acute coronary syndromes
Param Maewal, James A de Lemos
Page
of 55
Search research articles
Search
Showing results (1-10 of 548) with videos related to
Sort By:
Page
of 55
Clinical Chemistry
|
February 17, 2019
Technology Meets Opportunity: High-Sensitivity Troponin Testing for Screening Apparently Healthy Adults
James A de Lemos
JAMA
|
June 6, 2013
Increasingly sensitive assays for cardiac troponins: a review
James A de Lemos
Archives of Internal Medicine
|
December 13, 2006
The latest and greatest new biomarkers: which ones should we measure for risk prediction in our practice?
James A de Lemos
JAMA
|
October 10, 2013
Assays for cardiac troponins--reply
James A de Lemos
Circulation. Cardiovascular Genetics
|
December 25, 2009
The report card on growth differentiation factor 15: consistent marks but not yet ready for promotion
Anand Rohatgi, James A de Lemos
Current Cardiology Reports
|
June 13, 2003
B-type natriuretic peptide in ischemic heart disease
Rajat Deo, James A de Lemos
Journal of the American College of Cardiology
|
November 21, 2007
The skinny on fatty acid-binding protein
James A de Lemos, Michelle O'Donoghue
Circulation
|
May 26, 2010
Separating the contenders from the pretenders: competitive high-throughput biomarker screening in large population-based studies
James A de Lemos, Anand Rohatgi
The New England Journal of Medicine
|
March 2, 2022
High-Sensitivity Troponin after Cardiac Surgery - Is the VISION Any Clearer?
James A de Lemos, Michael Jessen
Heart Failure Reviews
|
October 24, 2003
Natriuretic peptide hormone measurement in acute coronary syndromes
Param Maewal, James A de Lemos
Page
of 55